SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 27.43+1.2%Nov 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Busse who wrote (1603)7/27/1999 12:02:00 PM
From: Robert Busse  Read Replies (1) of 1693
 
Glaxo just received FDA approval for Relenza, their influenza drug - this is great news for Quidel, and I certainly hope Quidel's influenza test is likewise approved shortly - Mr deBruin indicated on the conference call that Q had applied simultaneously w/ FDA and w/ CDC for CLIA waiver- let's hope approval is forthcoming shortly from both.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext